Supplement encyclopedia

Potassium

Potassium is a mineral element obtained from food and supplements.

Double-check the conclusions and read the sources before choosing a supplement.

Main conclusion

What it may offer

  • Microencapsulated potassium chloride may help young healthy men on a low-potassium diet spend less time awake after falling asleep. A sleep sensor showed this result in one small study after a week of 96 mEq a day (about 3750 mg of potassium).
  • Total sleep time did not increase with this regimen, and the diary-recorded sleep interval was shorter and depended on the order of administration.
  • Potassium citrate may slightly increase lumbar spine bone density in healthy people over 65 without osteoporosis. With 60 mEq a day (about 2350 mg of potassium) alongside calcium and vitamin D for two years, density was 1.7% higher than with placebo on the same background.
  • In two other trials in postmenopausal women, including women with osteopenia, potassium citrate showed no convincing improvement in bone density compared with placebo over 12–24 months.
  • In people without hypertension, a review of four short trials found no convincing reduction in the upper, or systolic, blood pressure.
  • In relatively healthy adults, potassium supplements did not significantly change resting heart rate on average.

[1] [2] [3] [4] [5] [6] [7]

What was studied

  • Sleep was assessed in one crossover study of nine young healthy men with one-week intake periods. Sensor records were available for six and diaries for nine.
  • Bone density was studied in three separate potassium citrate trials: in 276 postmenopausal women, 83 women with osteopenia and 201 healthy adults over 65.
  • Blood pressure in people without hypertension was assessed using four trials from a review of ten. Resting heart rate was studied in a separate review of 22 trials with 1086 participants.

[1] [2] [3] [4] [5] [6]

Which forms were considered

  • Supplements contain potassium chloride, citrate and gluconate: check the ingredients for the form.
  • Compare the amount of elemental potassium on the label, rather than the weight of the salt: these numbers differ.

[1]

How to get it from food

  • Potatoes, legumes, vegetables and fruit can provide potassium from food.
  • Milk, yoghurt, meat and fish also contain potassium; foods in the diet together contribute to its intake.

[1]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Sleep efficiency by actigraphyAutomated actigraphy showed higher sleep efficiency than placebo; the difference was not statistically significant with manual scoring.93.8±3.2% versus 89.2±5.1%, p<0.05. Manual scoring was not statistically significant.
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.
11 crossover trial (9 participants; 6 sensor records; four measures from one study)Potassium affects actigraph-identified sleep ↗9 young healthy men with normal serum potassium; actigraphy in 6
  1. Potassium affects actigraph-identified sleep ↗
Wakefulness after sleep onsetAutomated actigraphy showed less time awake after falling asleep than placebo; the difference was not statistically significant with manual scoring.25.8±15.0 versus 47.4±20.9 min, p<0.05. Manual scoring was not statistically significant.
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.
11 crossover trial (9 participants; 6 sensor records; four measures from one study)Potassium affects actigraph-identified sleep ↗9 young healthy men with normal serum potassium; actigraphy in 6
  1. Potassium affects actigraph-identified sleep ↗
Diary-recorded sleep intervalThe diary-recorded sleep interval was shorter than with placebo; the result depended on intervention order.416±52 versus 439±56 min, p<0.01 in the abstract; interaction with order p=0.04.
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.
11 crossover trial (9 participants; 6 sensor records; four measures from one study)Potassium affects actigraph-identified sleep ↗9 young healthy men with normal serum potassium; actigraphy in 6
  1. Potassium affects actigraph-identified sleep ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake referencesAdequate potassium intake from all sources for healthy adults: 3400 mg/day for men and 2600 mg/day for women. This is not a standalone supplement dose or a target for people with impaired potassium excretion.
Intake referencesFor pregnant adults, the total-intake reference is 2900 mg/day, for breastfeeding adults 2800 mg/day; for children aged 1–3, 2000 mg/day, and aged 4–8, 2300 mg/day. These values concern all food and supplements combined.

Potassium - Health Professional Fact Sheet ↗

Forms

Potassium is a mineral element. On the label, the amount of elemental potassium differs from the weight of its salt, such as chloride or citrate. Supplements use potassium chloride, citrate, gluconate and other salts. Supplement Facts states the amount of elemental potassium. Most US supplements contain no more than 99 mg per serving; this describes the market, not a universally safe dose.

Guidance for each goal

Sleep efficiency by actigraphy1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.

Automated actigraphy showed higher sleep efficiency than placebo; the difference was not statistically significant with manual scoring.

Study findings. Automated actigraphy showed higher sleep efficiency than placebo; the difference was not statistically significant with manual scoring.

Studied regimen96 mEq of potassium a day as chlorideMicroencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food
Duration and population1 week per period, crossover9 young healthy men with normal serum potassium; actigraphy in 6

Comparison: Placebo on the same diet

Wakefulness after sleep onset1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.

Automated actigraphy showed less time awake after falling asleep than placebo; the difference was not statistically significant with manual scoring.

Study findings. Automated actigraphy showed less time awake after falling asleep than placebo; the difference was not statistically significant with manual scoring.

Studied regimen96 mEq of potassium a day as chlorideMicroencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food
Duration and population1 week per period, crossover9 young healthy men with normal serum potassium; actigraphy in 6

Comparison: Placebo on the same diet

Diary-recorded sleep interval1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.

The diary-recorded sleep interval was shorter than with placebo; the result depended on intervention order.

Study findings. The diary-recorded sleep interval was shorter than with placebo; the result depended on intervention order.

Studied regimen96 mEq of potassium a day as chlorideMicroencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food
Duration and population1 week per period, crossover9 young healthy men with normal serum potassium; actigraphy in 6

Comparison: Placebo on the same diet

Total sleep time by actigraphy1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Three records lost, dependence on method or order. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific restricted diet and short protocol. Precision of the estimate: 9 participants, actigraphy in 6. Possible publication bias: There are no specific data for a separate downgrade.

Automated actigraphy showed no convincing increase in total sleep time.

Study findings. Automated actigraphy showed no convincing increase in total sleep time.

Studied regimen96 mEq of potassium a day as chlorideMicroencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food
Duration and population1 week per period, crossover9 young healthy men with normal serum potassium; actigraphy in 6

Comparison: Placebo on the same diet

Systolic blood pressure2/4 LowRead moreCollapse
Confidence
2/4 LowStudy methods: Limitations in reporting and analysis of short trials. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A dose model based on urinary excretion and different forms limit extrapolation to a specific capsule. Precision of the estimate: Enough data for a limited conclusion. Possible publication bias: There are no specific data for a separate downgrade.

No convincing reduction in systolic blood pressure was found in people without hypertension.

Study findings. No convincing reduction in systolic blood pressure was found in people without hypertension.

Studied regimenModel: +30 mmol of potassium a day based on 24-hour urinary excretion; this measures excretion, not the supplement dose takenDifferent oral forms of potassium supplementation
Duration and population1–6 weeksParticipants without hypertension in 4 RCTs; 10 RCTs in the whole review

Comparison: Lower intake

Bone mineral density1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Attrition and limitations of subgroup analyses. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: BMD and a specific clinical group limit extrapolation to fractures. Precision of the estimate: Uncertain precision by dose or site. Possible publication bias: There are no specific data for a separate downgrade.

No convincing improvement in bone mineral density was found in postmenopausal women.

Study findings. No convincing improvement in bone mineral density was found in postmenopausal women.

Studied regimen18.5 or 55.5 mEq/dayPotassium citrate
Duration and population24 months276 postmenopausal women

Comparison: Placebo; fruit-and-vegetable diet was a separate condition

Bone mineral density1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Attrition and limitations of subgroup analyses. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: BMD and a specific clinical group limit extrapolation to fractures. Precision of the estimate: Uncertain precision by dose or site. Possible publication bias: There are no specific data for a separate downgrade.

No convincing change in lumbar spine or hip bone density was found in postmenopausal women with osteopenia.

Study findings. No convincing change in lumbar spine or hip bone density was found in postmenopausal women with osteopenia.

Studied regimen40 mEq/dayPotassium citrate
Duration and population12 months83 postmenopausal women with osteopenia

Comparison: Placebo with the same background calcium and D₃

Lumbar spine bone mineral density1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudy methods: Small study or incomplete description of randomisation and attrition. Consistency of results: Consistency of the single study's results is unknown. Applicability to the stated group: Features of the group, dose or indirect measure limit extrapolation. Precision of the estimate: Small sample and wide or unspecified confidence interval. Possible publication bias: Cannot be assessed.

In healthy people over 65, lumbar spine density increased relative to placebo; a reduction in fractures has not been established.

Study findings. In healthy people over 65, lumbar spine density increased relative to placebo; a reduction in fractures has not been established.

Studied regimen60 mEq of potassium/day as citrate; both groups received calcium and vitamin DPotassium citrate with the same background calcium and vitamin D
Duration and population24 months201 healthy adults over 65

Comparison: Placebo with the same background calcium and vitamin D

Resting heart rate2/4 LowRead moreCollapse
Confidence
2/4 LowStudy methods: Included trials have reporting limitations and participant attrition. Consistency of results: Participant groups and products varied. Applicability to the stated group: Mixtures or salt substitutes change several components at once. Precision of the estimate: A pooled interval is provided for the stated outcome. Possible publication bias: Not established.

In relatively healthy adults, average resting heart rate did not change significantly.

Study findings. In relatively healthy adults, average resting heart rate did not change significantly.

Studied regimenMedian 2.5 g of elemental potassium/day; dose range in the review 0.9–4.7 g/dayOral potassium supplements of different salts in placebo-controlled trials
Duration and populationMedian 4 weeks; range 2–24 weeks1086 relatively healthy adults in 22 placebo-controlled studies

Comparison: Placebo

Safety and limitations

No upper limit for total potassium intake has been established for healthy people with normal kidney function. Large doses of supplements or salt substitutes can cause a dangerous rise in blood potassium, sometimes without obvious symptoms. In chronic kidney disease, heart or adrenal failure and other conditions with impaired potassium excretion, ordinary references for healthy people cannot be considered an individually safe dose. Potassium supplements may cause gastrointestinal discomfort. Small-intestinal injury, bleeding and obstruction have been described for some medicinal potassium salts; the risk cannot automatically be transferred to every supplement form. Salt substitutes may provide about 440–2800 mg of elemental potassium per teaspoon depending on their composition. This counts towards total intake and is especially important with kidney disease and medicines that raise potassium. In a review of different citrate salts in adults with calcium-containing stones, discontinuation due to adverse events was more frequent: RR 4.45 (95% CI 1.28–15.50), 4 studies and 271 participants. The review includes potassium citrate and mixtures with sodium or magnesium. In the same review of different citrate salts, gastrointestinal adverse events were estimated uncertainly: RR 2.55 (95% CI 0.71–9.16), 4 studies and 271 participants. These data concern patients with calcium-containing stones, including mixed citrate products. In an uncontrolled run-in period in 191 patients with chronic kidney disease G3b–G4, after two weeks of 40 mmol of potassium chloride a day, hyperkalaemia was found in 21 people (11%). 83% took renin–angiotensin system inhibitors; there was no placebo comparison group. Low dietary potassium intake and hypokalaemia are different conditions. Low blood potassium may be associated with diarrhoea, vomiting or diuretics; a marked decrease can disrupt heart rhythm. Magnesium deficiency may increase urinary potassium loss in hypokalaemia. This is a separate situation and does not prove a benefit from adding both minerals when balance is normal.

Potassium - Health Professional Fact Sheet ↗ · Citrate salts for preventing and treating calcium containing kidney stones in adults ↗ · Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD ↗

Interactions

WithEffectActionSource
ACE inhibitors, such as benazeprilMay reduce potassium excretion and raise its blood level.Discuss potassium intake and the need to monitor its level with a doctor, especially with kidney disease.Potassium - Health Professional Fact Sheet ↗
Angiotensin receptor blockers, such as losartanMay reduce potassium excretion and raise its blood level.Discuss potassium intake and the need to monitor its level with a doctor, especially with kidney disease.Potassium - Health Professional Fact Sheet ↗
Potassium-sparing diuretics, such as spironolactone and amilorideReduce potassium excretion and may cause excess potassium in the blood.Discuss potassium supplements and salt substitutes and the need to monitor potassium with a doctor.Potassium - Health Professional Fact Sheet ↗
Loop diuretics, such as furosemideIncrease urinary potassium loss and may lower its blood level.Discuss potassium monitoring with a doctor; the need for a supplement is determined individually.Potassium - Health Professional Fact Sheet ↗
Thiazide diuretics, such as chlorothiazideIncrease urinary potassium loss and may lower its blood level.Discuss potassium monitoring with a doctor; the need for a supplement is determined individually.Potassium - Health Professional Fact Sheet ↗

Food sources

Potassium is shown for the edible portion of the stated food in the stated condition. Weights were chosen for comparison; potassium amounts and calories were calculated from one USDA record per 100 g. Potassium requirements and allowable amounts depend on kidney function and medicines.

Vegetables and potatoes

Potassium is found in potatoes and other vegetables.

Potassium - Consumer Fact Sheet ↗

Legumes

Potassium is found in beans and lentils.

Potassium - Consumer Fact Sheet ↗

Fruit

Sources of potassium include bananas, avocados and oranges.

Potassium - Consumer Fact Sheet ↗

Dairy products

Milk and yoghurt contain potassium.

Potassium - Consumer Fact Sheet ↗

Meat, fish and nuts

Potassium is present in meat, fish and nuts.

Potassium - Consumer Fact Sheet ↗

Food composition

FoodGroupAmountServingCaloriesSources
Potatobaked, flesh and skin, without saltVegetables535 mg of potassium / 100 g150 g · 802.5 mg of potassium · 139.5 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.93 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Spinachboiled, drained, without saltVegetables466 mg of potassium / 100 g90 g · 419.4 mg of potassium · 20.7 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.23 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Tomatored, ripe, raw, edible portionVegetables237 mg of potassium / 100 g100 g · 237 mg of potassium · 18 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.18 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
Black beansmature seeds, boiled, without added saltLegumes355 mg of potassium / 100 g100 g · 355 mg of potassium · 132 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.132 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Lentilsmature seeds, boiled, without added saltLegumes369 mg of potassium / 100 g100 g · 369 mg of potassium · 116 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.116 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
Bananaraw, edible portionFruit358 mg of potassium / 100 g100 g · 358 mg of potassium · 89 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.89 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 09 ↗
Avocadoraw, edible partFruit485 mg of potassium / 100 g100 g · 485 mg of potassium · 160 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.160 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 09 ↗
Orangeraw, edible portionFruit181 mg of potassium / 100 g100 g · 181 mg of potassium · 47 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.47 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 09 ↗
Milkwhole, 3.25% fat, without added vitamins A and DDairy products132 mg of potassium / 100 g200 g · 264 mg of potassium · 122 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.61 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
Yoghurtplain, low-fat, 12 g of protein per 8 ouncesDairy products234 mg of potassium / 100 g170 g · 397.8 mg of potassium · 107.1 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.63 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
Sockeye salmoncooked with dry heatFish436 mg of potassium / 100 g85 g · 370.6 mg of potassium · 132.6 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.156 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Pork tenderloinroasted, separable lean meatMeat421 mg of potassium / 100 g85 g · 357.85 mg of potassium · 121.55 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.143 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 10 ↗
Almondsdry-roasted, without added saltNuts713 mg of potassium / 100 g30 g · 213.9 mg of potassium · 179.4 kcalSelected comparison weight of the edible portion; potassium and energy calculated from data per 100 g.598 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Potassium affects actigraph-identified sleep ↗Sleep efficiency by actigraphy: Sleep efficiency by actigraphy Wakefulness after sleep onset: Wakefulness after sleep onset Diary-recorded sleep interval: Diary-recorded sleep interval Total sleep time by actigraphy: Total sleep time by actigraphySleep efficiency by actigraphy: 9 young healthy men with normal serum potassium; actigraphy in 6 Wakefulness after sleep onset: 9 young healthy men with normal serum potassium; actigraphy in 6 Diary-recorded sleep interval: 9 young healthy men with normal serum potassium; actigraphy in 6 Total sleep time by actigraphy: 9 young healthy men with normal serum potassium; actigraphy in 6Sleep efficiency by actigraphy: Microencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food; 96 mEq of potassium a day as chloride; 1 week per period, crossover; comparison: Placebo on the same diet Wakefulness after sleep onset: Microencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food; 96 mEq of potassium a day as chloride; 1 week per period, crossover; comparison: Placebo on the same diet Diary-recorded sleep interval: Microencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food; 96 mEq of potassium a day as chloride; 1 week per period, crossover; comparison: Placebo on the same diet Total sleep time by actigraphy: Microencapsulated potassium chloride (Micro-K); diet providing about 40 mEq of potassium a day from food; 96 mEq of potassium a day as chloride; 1 week per period, crossover; comparison: Placebo on the same dietSleep efficiency by actigraphy: Automated actigraphy showed higher sleep efficiency than placebo; the difference was not statistically significant with manual scoring. Wakefulness after sleep onset: Automated actigraphy showed less time awake after falling asleep than placebo; the difference was not statistically significant with manual scoring. Diary-recorded sleep interval: The diary-recorded sleep interval was shorter than with placebo; the result depended on intervention order. Total sleep time by actigraphy: Automated actigraphy showed no convincing increase in total sleep time.
Effect of changes in potassium intake on blood pressure: a dose-response meta-analysis of randomized clinical trials (2000-2024) ↗Systolic blood pressureParticipants without hypertension in 4 RCTs; 10 RCTs in the whole reviewDifferent oral forms of potassium supplementation; Model: +30 mmol of potassium a day based on 24-hour urinary excretion; this measures excretion, not the supplement dose taken; 1–6 weeks; comparison: Lower intakeNo convincing reduction in systolic blood pressure was found in people without hypertension.

Sources

Sources
  1. Potassium affects actigraph-identified sleep ↗
  2. Effect of changes in potassium intake on blood pressure: a dose-response meta-analysis of randomized clinical trials (2000-2024) ↗
  3. Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial ↗
  4. POTASSIUM CITRATE DECREASES BONE RESORPTION IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL ↗
  5. Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial ↗
  6. Potassium supplementation and heart rate: A meta-analysis of randomized controlled trials ↗
  7. Potassium - Health Professional Fact Sheet ↗
  8. Potassium - Consumer Fact Sheet ↗
  9. Citrate salts for preventing and treating calcium containing kidney stones in adults ↗
  10. Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD ↗
  11. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 11 ↗
  12. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 16 ↗
  13. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 09 ↗
  14. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 01 ↗
  15. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
  16. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 10 ↗
  17. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗